NCT03860610

Brief Summary

Study 1 is to determine if muscle strength and dynamic and postural stability are compromised in patients with severe hip or knee Osteoarthritis (OA) and in patients after THA and TKA. Study 2 is to quantify the effect of THA and TKA on muscle strength and dynamic and postural stability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 10, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 26, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 4, 2019

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 7, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 7, 2021

Completed
Last Updated

March 4, 2022

Status Verified

March 1, 2022

Enrollment Period

3 years

First QC Date

February 26, 2019

Last Update Submit

March 3, 2022

Conditions

Keywords

Total Hip ArthroplastyTotal Knee ArthroplastyOsteoarthritisMuscle strength deficitsDynamic stability

Outcome Measures

Primary Outcomes (6)

  • Muscle strength (Study 1)

    For the knee, maximum isokinetic flexion and extension torques will be collected between full extension and 90° flexion at a movement speed of 60°/s (5 repetitions) and 240°/s (5 repetitions).For the hip, maximum abduction torques will be measured isometrically (5 repetitions) in a standing position. Maximum joint torques in each movement direction will be recorded for each joint and normalized to body weight (study group 1 to 5)

    single point measurement at Visit A (week 0)

  • Change in Muscle strength (Study 2)

    For the knee, maximum isokinetic flexion and extension torques will be collected between full extension and 90° flexion at a movement speed of 60°/s (5 repetitions) and 240°/s (5 repetitions).For the hip, maximum abduction torques will be measured isometrically (5 repetitions) in a standing position. Maximum joint torques in each movement direction will be recorded for each joint and normalized to body weight (study group 3 and 4)

    Three assessments will be performed: preoperatively (visit 1), 6 weeks postoperatively (visit 2) and 1 year postoperative (visit 3).

  • Postural stability (Study 1)

    The overall stability index (OSI) will be assessed using the Biodex Balance System SD. A high stability index represents the angular excursion of the subject's center of gravity and is indicative of a high degree of movement during a test (i.e.poor balance). (study group 1 to 5)

    single point measurement at Visit A (week 0)

  • Change in postural stability (Study 2)

    The overall stability index (OSI) will be assessed using the Biodex Balance System SD. A high stability index represents the angular excursion of the subject's center of gravity and is indicative of a high degree of movement during a test (i.e.poor balance).(study group 3 and 4)

    Three assessments will be performed: preoperatively (visit 1), 6 weeks postoperatively (visit 2) and 1 year postoperative (visit 3).

  • Dynamic stability (Study 1)

    Instrumented gait analysis on an overground walkway to compute step width for each step from a pressure plate built into the treadmill (study group 1 to 5)

    single point measurement at Visit A (week 0)

  • Change in dynamic stability (Study 2)

    Instrumented gait analysis on an overground walkway to compute step width for each step from a pressure plate built into the treadmill (study group 3 and 4)

    Three assessments will be performed: preoperatively (visit 1), 6 weeks postoperatively (visit 2) and 1 year postoperative (visit 3).

Study Arms (5)

Patient group 1 after THA

Patients who have already received a THA (N=30) for OA will be assessed 1 year postoperatively (Visit A); Interventions in this Group: 'Muscle strength test', 'Dynamic stability test during level and uphill walking', 'Postural stability test', 'EuroQol Group Health questionnaire (EQ-5D-5L)', 'HOOS/ KOOS', ' Muscle activity test', 'Passive range of motion'

Diagnostic Test: Muscle strength testDiagnostic Test: Dynamic stability test during level and uphill walkingDiagnostic Test: Postural stability testDiagnostic Test: EuroQol Group Health questionnaire (EQ-5D-5L)Diagnostic Test: HOOS/ KOOSDiagnostic Test: Muscle activity testDiagnostic Test: Passive range of motion

Patient group 2 after TKA

Patients who have already received a TKA (N=30) for OA will be assessed 1 year postoperatively (Visit A); Interventions in this Group: 'Muscle strength test', 'Dynamic stability test during level and uphill walking', 'Postural stability test', 'EuroQol Group Health questionnaire (EQ-5D-5L)', 'HOOS/ KOOS', ' Muscle activity test', 'Passive range of motion'

Diagnostic Test: Muscle strength testDiagnostic Test: Dynamic stability test during level and uphill walkingDiagnostic Test: Postural stability testDiagnostic Test: EuroQol Group Health questionnaire (EQ-5D-5L)Diagnostic Test: HOOS/ KOOSDiagnostic Test: Muscle activity testDiagnostic Test: Passive range of motion

Patient group 3 before THA

Patients with severe hip OA (N=30) scheduled to receive a THA will be assessed preoperatively (Visit 1), 12 weeks postoperative (Visit 2) and 1 year postoperative (Visit 3). Interventions in this Group: 'Muscle strength test', 'Dynamic stability test during level and uphill walking', 'Postural stability test', 'EuroQol Group Health questionnaire (EQ-5D-5L)', 'HOOS/ KOOS', ' Muscle activity test', 'Passive range of motion'

Diagnostic Test: Muscle strength testDiagnostic Test: Dynamic stability test during level and uphill walkingDiagnostic Test: Postural stability testDiagnostic Test: EuroQol Group Health questionnaire (EQ-5D-5L)Diagnostic Test: HOOS/ KOOSDiagnostic Test: Muscle activity testDiagnostic Test: Passive range of motion

Patient group 4 before TKA

Patients with severe knee OA (N=30) scheduled to receive a TKA will be assessed preoperatively (Visit 1), 12 weeks postoperative (Visit 2) and 1 year postoperative (Visit 3). Interventions in this Group: 'Muscle strength test', 'Dynamic stability test during level and uphill walking', 'Postural stability test', 'EuroQol Group Health questionnaire (EQ-5D-5L)', 'HOOS/ KOOS', ' Muscle activity test', 'Passive range of motion'

Diagnostic Test: Muscle strength testDiagnostic Test: Dynamic stability test during level and uphill walkingDiagnostic Test: Postural stability testDiagnostic Test: EuroQol Group Health questionnaire (EQ-5D-5L)Diagnostic Test: HOOS/ KOOSDiagnostic Test: Muscle activity testDiagnostic Test: Passive range of motion

Healthy control group

Age-matched healthy control subjects (N=30);Interventions in this Group: 'Muscle strength test', 'Dynamic stability test during level and uphill walking', 'Postural stability test', 'EuroQol Group Health questionnaire (EQ-5D-5L)', 'HOOS/ KOOS', ' Muscle activity test', 'Passive range of motion'

Diagnostic Test: Muscle strength testDiagnostic Test: Dynamic stability test during level and uphill walkingDiagnostic Test: Postural stability testDiagnostic Test: EuroQol Group Health questionnaire (EQ-5D-5L)Diagnostic Test: HOOS/ KOOSDiagnostic Test: Muscle activity testDiagnostic Test: Passive range of motion

Interventions

Muscle strength testDIAGNOSTIC_TEST

Muscle strength in knee flexion and extension and hip abduction will be tested using using a dynamometer (Biodex System 4 Pro: Biodex Medical Systems, Shirley, NY, USA)

Healthy control groupPatient group 1 after THAPatient group 2 after TKAPatient group 3 before THAPatient group 4 before TKA

Instrumented gait analysis on an overground walkway with two embedded force plates (Kistler force plate 9260AA6, Kistler AG, Winterthur, Switzerland; sampling rate 2400 Hz) and on a treadmill with an embedded plantar pressure plate (h/p/cosmos, Zebris FDM-T, Isny, Germany)

Healthy control groupPatient group 1 after THAPatient group 2 after TKAPatient group 3 before THAPatient group 4 before TKA

The overall stability index (OSI) will be assessed using the Biodex Balance System SD (Biodex Medical Systems, Inc., Shirley, NY, USA) and is determined by the variance in platform displacement from the horizontal plane.

Healthy control groupPatient group 1 after THAPatient group 2 after TKAPatient group 3 before THAPatient group 4 before TKA

Overall health will be assessed using the EQ-5D-5L health questionnaire

Healthy control groupPatient group 1 after THAPatient group 2 after TKAPatient group 3 before THAPatient group 4 before TKA
HOOS/ KOOSDIAGNOSTIC_TEST

Site specific pain and function will be assessed with the Hip Osteoarthritis Outcome Score (HOOS) and Knee Injury and Osteoarthritis Outcome Score (KOOS) depending on the affected joint (hip or knee).

Healthy control groupPatient group 1 after THAPatient group 2 after TKAPatient group 3 before THAPatient group 4 before TKA
Muscle activity testDIAGNOSTIC_TEST

Surface electrodes (Ag/AgCl, Noraxon, U.S.A. Inc., Scottsdale, AZ, USA: 10 mm diameter, 22 mm inter-electrode distance) will be placed bilaterally on glutaeus medius, vastus medialis, semitendinosus, tibialis anterior, gastrocnemius medialis, and peroneus longus muscles. Periods of muscle activity will be defined as intensity above 2 Standard Deviation (SD) of the resting Electromyography (EMG) signal. Duration of overlapping muscle activity between agonists and antagonists normalized to one gait cycle or of a balance test, respectively, will be determined.

Healthy control groupPatient group 1 after THAPatient group 2 after TKAPatient group 3 before THAPatient group 4 before TKA

Passive range of motion will be assessed for ankle plantar-/dorsiflexion, knee flexion/extension and hip flexion/extension, ab/adduction, internal/external rotation using goniometers and recorded in degrees. The range between two maxima will be recorded.

Healthy control groupPatient group 1 after THAPatient group 2 after TKAPatient group 3 before THAPatient group 4 before TKA

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Participants will be recruited by consecutive recruitment through the contributing surgeons in daily clinical practice, referring physicians and advertisements placed bi-monthly in the University of Basel "Uni-news" and ongoing on the department website. Healthy participants will be recruited by advertisements placed bi-monthly in the University of Basel "Uni-news", local health and sports clubs and ongoing on the department website.

You may qualify if:

  • Patients with an unilateral THA or TKA, which they received for the treatment of osteoarthritis (Patient groups 1+2)
  • Patients diagnosed with unilateral OA of the knee or hip planned for a treatment with THA or TKA (Patient groups 3+4)
  • Age ≥ 30 years (Healthy control group)

You may not qualify if:

  • Body mass index \> 35kg/m2
  • Use of walking aids
  • Neuromuscular disorders affecting gait
  • Inability to follow procedures due to psychological disorders or dementia
  • Diagnosed hip or knee OA (Healthy control group)
  • Current pain in the lower extremities or lower back (Healthy control group)
  • Rheumatoid Arthritis (Healthy control group)
  • Previous corrective osteotomy (Healthy control group)
  • Regular intake of pain medication (more than 4 times per week) (Healthy control group)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Orthopaedics and Traumatology, University Hospital Basel

Basel, 4031, Switzerland

Location

MeSH Terms

Conditions

Osteoarthritis

Interventions

Range of Motion, Articular

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Physical ExaminationDiagnostic Techniques and ProceduresDiagnosisMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Annegret Muendermann, Prof. Dr. MD

    Department of Orthopaedics and Traumatology, University Hospital Basel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2019

First Posted

March 4, 2019

Study Start

December 10, 2018

Primary Completion

December 7, 2021

Study Completion

December 7, 2021

Last Updated

March 4, 2022

Record last verified: 2022-03

Locations